Maternal opioid addiction: A potential cause of elevated 17-OH progesterone in neonatal screening.
Fiche publication
Date publication
décembre 2022
Journal
Archives de pediatrie : organe officiel de la Societe francaise de pediatrie
Auteurs
Membres identifiés du Cancéropôle Est :
Pr ALBUISSON Eliane
Tous les auteurs :
Francois-Bic S, Legagneur C, Hubert C, Guéant-Rodriguez RM, Leheup B, Albuisson E, Renard E
Lien Pubmed
Résumé
Congenital adrenal hyperplasia (CAH) is a disease that is part of neonatal screening. There are many causes of false-positive results on neonatal screening, and maternal opioid consumption during pregnancy is suspected to increase 17-hydroxyprogesterone (17-OHP) levels at birth. The aim of this study was to determine the effect of maternal drug consumption on 17-OHP values on neonatal screening.
Mots clés
17 OH progesterone, Maternal, Neonatal screening, Opioid addiction
Référence
Arch Pediatr. 2022 12 14;: